• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道菌群对痛风性关节炎影响的研究。

Study on the effects of intestinal flora on gouty arthritis.

机构信息

Yunnan University of Traditional Chinese Medicine, Kunming, China.

出版信息

Front Cell Infect Microbiol. 2024 Aug 8;14:1341953. doi: 10.3389/fcimb.2024.1341953. eCollection 2024.

DOI:10.3389/fcimb.2024.1341953
PMID:39176260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11339034/
Abstract

Gouty arthritis (GA), a metabolic and immunologic disease, primarily affects joints. Dysbiosis of intestinal flora is an important cause of GA. The metabolic disorders of intestinal flora leading to GA and immune disorders might play an important role in patients with hyperuricemia and established GA. However, the exact mechanisms, through which the dysbiosis of intestinal flora causes the development of GA, are not fully understood yet. Moreover, several therapies commonly used to treat GA might alter the intestinal flora, suggesting that modulation of the intestinal flora might help prevent or treat GA. Therefore, a better understanding of the changes in the intestinal flora of GA patients might facilitate the discovery of new diagnostic and therapeutic approaches. The current review article discusses the effects of intestinal flora dysbiosis on the pathogenesis of GA and the cross-regulatory effects between gut flora and drugs for treating GA. This article also highlights the modulatory effects of gut flora by traditional Chinese medicine (TCM) to lower uric acid levels and relieve joint pain as well as provides a summary and outlook, which might help guide future research efforts.

摘要

痛风性关节炎(GA)是一种代谢和免疫性疾病,主要影响关节。肠道菌群失调是 GA 的重要原因。肠道菌群代谢紊乱导致 GA 和免疫紊乱可能在高尿酸血症和已确诊 GA 患者中发挥重要作用。然而,肠道菌群失调导致 GA 发展的确切机制尚不完全清楚。此外,几种常用于治疗 GA 的疗法可能会改变肠道菌群,这表明调节肠道菌群可能有助于预防或治疗 GA。因此,更好地了解 GA 患者肠道菌群的变化可能有助于发现新的诊断和治疗方法。本文综述了肠道菌群失调对 GA 发病机制的影响,以及肠道菌群与治疗 GA 的药物之间的交叉调节作用。本文还强调了中药(TCM)调节肠道菌群以降低尿酸水平和缓解关节疼痛的作用,并提供了总结和展望,可能有助于指导未来的研究工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba46/11339034/57a37ea11549/fcimb-14-1341953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba46/11339034/32fc903a4a43/fcimb-14-1341953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba46/11339034/57a37ea11549/fcimb-14-1341953-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba46/11339034/32fc903a4a43/fcimb-14-1341953-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba46/11339034/57a37ea11549/fcimb-14-1341953-g002.jpg

相似文献

1
Study on the effects of intestinal flora on gouty arthritis.肠道菌群对痛风性关节炎影响的研究。
Front Cell Infect Microbiol. 2024 Aug 8;14:1341953. doi: 10.3389/fcimb.2024.1341953. eCollection 2024.
2
[Modern understanding of uric acid metabolism disorders and progress in traditional Chinese medicine prevention and treatment].[尿酸代谢紊乱的现代认识与中医防治进展]
Zhongguo Zhong Yao Za Zhi. 2024 Jun;49(12):3160-3167. doi: 10.19540/j.cnki.cjcmm.20240226.501.
3
Guizhi Shaoyao Zhimu Decoction ameliorates gouty arthritis in rats via altering gut microbiota and improving metabolic profile.桂枝芍药知母汤通过改变肠道微生物群和改善代谢谱来改善大鼠痛风性关节炎。
Phytomedicine. 2024 Aug;131:155800. doi: 10.1016/j.phymed.2024.155800. Epub 2024 Jun 3.
4
[Research progress on anti-hyperuricemia effects and mechanisms of Chinese medicines based on regulation of intestinal flora and metabolites].基于肠道菌群及其代谢产物调控的中药抗高尿酸血症作用及机制研究进展
Zhongguo Zhong Yao Za Zhi. 2021 Dec;46(24):6387-6394. doi: 10.19540/j.cnki.cjcmm.20210918.702.
5
Effect and mechanism of aqueous extract of Chinese herbal prescription (TFK) in treating gout arthritis.中药方剂(TFK)水提物治疗痛风性关节炎的作用及机制。
J Ethnopharmacol. 2024 Mar 1;321:117527. doi: 10.1016/j.jep.2023.117527. Epub 2023 Dec 4.
6
Phytochemicals in traditional Chinese medicine can treat gout by regulating intestinal flora through inactivating NLRP3 and inhibiting XOD activity.中药中的植物化学物质可以通过抑制 NLRP3 和 XOD 活性来调节肠道菌群,从而治疗痛风。
J Pharm Pharmacol. 2022 Jul 15;74(7):919-929. doi: 10.1093/jpp/rgac024.
7
Microneedle transdermal drug delivery as a candidate for the treatment of gouty arthritis: Material structure, design strategies and prospects.微针经皮给药系统治疗痛风性关节炎的研究进展:材料结构、设计策略及前景展望。
Acta Biomater. 2024 Oct 1;187:20-50. doi: 10.1016/j.actbio.2024.08.032. Epub 2024 Sep 3.
8
Intestinal Flora: A Pivotal Role in Investigation of Traditional Chinese Medicine.肠道菌群:中药研究的关键角色。
Am J Chin Med. 2021;49(2):237-268. doi: 10.1142/S0192415X21500130. Epub 2021 Feb 20.
9
Gut microbiota and rheumatoid arthritis: From pathogenesis to novel therapeutic opportunities.肠道微生物群与类风湿关节炎:从发病机制到新的治疗机会。
Front Immunol. 2022 Sep 8;13:1007165. doi: 10.3389/fimmu.2022.1007165. eCollection 2022.
10
In vivo anti-hyperuricemia and anti-gouty arthritis effects of the ethanol extract from Amomumvillosum Lour.阳春砂乙醇提取物的体内抗高尿酸血症及抗痛风性关节炎作用
Biomed Pharmacother. 2023 May;161:114532. doi: 10.1016/j.biopha.2023.114532. Epub 2023 Mar 14.

引用本文的文献

1
The dual regulatory effects of intestinal microorganisms and their metabolites in gouty arthritis pathogenesis: a balance between promotion and inhibition.肠道微生物及其代谢产物在痛风性关节炎发病机制中的双重调节作用:促进与抑制之间的平衡
Front Immunol. 2025 Jun 18;16:1591369. doi: 10.3389/fimmu.2025.1591369. eCollection 2025.

本文引用的文献

1
The Impact of mHealth-Based Continuous Care on Disease Knowledge, Treatment Compliance, and Serum Uric Acid Levels in Chinese Patients With Gout: Randomized Controlled Trial.基于移动医疗的连续护理对中国痛风患者疾病知识、治疗依从性和血尿酸水平的影响:随机对照试验。
JMIR Mhealth Uhealth. 2024 Apr 11;12:e47012. doi: 10.2196/47012.
2
Resveratrol Improves Hyperuricemia and Ameliorates Renal Injury by Modulating the Gut Microbiota.白藜芦醇通过调节肠道微生物群改善高尿酸血症并减轻肾损伤。
Nutrients. 2024 Apr 7;16(7):1086. doi: 10.3390/nu16071086.
3
Gut microbiota mediated the therapeutic efficiency of Simiao decoction in the treatment of gout arthritis mice.
肠道微生物群介导四妙汤治疗痛风性关节炎小鼠的疗效。
BMC Complement Med Ther. 2023 Jun 21;23(1):206. doi: 10.1186/s12906-023-04042-4.
4
Integrated network pharmacology and gut microbiome analysis to reveal the mechanism of Qu-Zhuo-Tong-Bi decoction against hyperuricemia and gout.基于网络药理学和肠道微生物组学分析揭示祛浊通痹方治疗高尿酸血症和痛风的作用机制。
J Ethnopharmacol. 2023 Nov 15;316:116736. doi: 10.1016/j.jep.2023.116736. Epub 2023 Jun 5.
5
Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?肠道微生物群在前列腺癌中的潜在作用:免疫、代谢产物、作用途径?
Front Oncol. 2023 May 17;13:1196217. doi: 10.3389/fonc.2023.1196217. eCollection 2023.
6
Investigation of the relationships among respiratory syncytial virus infection, T cell immune response and intestinal flora.呼吸道合胞病毒感染、T细胞免疫反应与肠道菌群之间关系的研究。
Eur Rev Med Pharmacol Sci. 2023 Mar;27(6):2671-2678. doi: 10.26355/eurrev_202303_31804.
7
Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs.肠道菌群对药物药代动力学和药效学的影响。
Drug Metab Rev. 2023 Feb-May;55(1-2):126-139. doi: 10.1080/03602532.2023.2186313. Epub 2023 Mar 14.
8
Modified Baihu decoction therapeutically remodels gut microbiota to inhibit acute gouty arthritis.加味白虎汤通过治疗性重塑肠道微生物群来抑制急性痛风性关节炎。
Front Physiol. 2022 Dec 15;13:1023453. doi: 10.3389/fphys.2022.1023453. eCollection 2022.
9
Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain.非甾体抗炎药、阿片类药物与肠道微生物群之间的相互作用——炎症和疼痛管理的未来展望。
Pharmacol Ther. 2023 Jan;241:108327. doi: 10.1016/j.pharmthera.2022.108327. Epub 2022 Dec 5.
10
CCFM1078 Alleviates Collagen-Induced Arthritis in Rats via Modulating the Gut Microbiota and Repairing the Intestinal Barrier Damage.CCFM1078 通过调节肠道微生物群和修复肠道屏障损伤来缓解大鼠胶原诱导性关节炎。
J Agric Food Chem. 2022 Nov 23;70(46):14665-14678. doi: 10.1021/acs.jafc.2c04602. Epub 2022 Nov 15.